awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36436763-2AC62498-B855-45AF-8196-BDBC5E1A1B60
Q36436763-2AC62498-B855-45AF-8196-BDBC5E1A1B60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36436763-2AC62498-B855-45AF-8196-BDBC5E1A1B60
Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer.
P2860
Q36436763-2AC62498-B855-45AF-8196-BDBC5E1A1B60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36436763-2AC62498-B855-45AF-8196-BDBC5E1A1B60
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c5b04f195af228428725274fc6ec5e44e0908b7
P2860
Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.